Intrafamilial heterogeneous clinical presentation of the mitochondrial 3243 MELAS mutation; molecular investigations

F Degoul1, M Diry, F Viader

  • 1INSERM U75, Faculté de médecine Necker Enfants-Malades, Université Paris V, F-75730 Paris Cedex 15Department of Neurology, CHU Côte de Nacre, F-14033 Caen CedexDivision Riesler, Hôpital de la Salpêtrière, 47 Bvd de I'hôpital, F-75013 ParisLaboratory of Anatomo-pathology, Hôpital Robert Debré, 48 Bvd Serrurier, F-75019 ParisDepartment of Anatomo-pathology and Cytology, Faculté de Médecine Toulouse-Rangueil, F-31034 Toulouse CedexLaboratory of Neuropathology, CHU Côte de Nacre, F-14033 Caen Cedex, France.

Insights

A specific mitochondrial DNA mutation (A3243G) was found in a patient with headaches, suspected due to her brother

Area of Science:

  • Genetics
  • Mitochondrial Biology
  • Neurology

Background:

  • Mitochondrial diseases can present with diverse and sometimes subtle clinical features.
  • The A3243G mutation in mitochondrial DNA is a known cause of MELAS syndrome.
  • Diagnosing mitochondrial disorders can be challenging, especially with atypical presentations.

Purpose of the Study:

  • To investigate the genetic basis of a patient's primary symptom of headache.
  • To explore the role of mitochondrial DNA mutations in a patient with a suspected, but unconfirmed, mitochondrial disorder.
  • To analyze the inheritance pattern and variability of a mitochondrial DNA mutation across multiple generations.

Main Methods:

  • Mitochondrial DNA analysis to identify specific point mutations.
  • Pedigree analysis across four generations to track mutation transmission.
  • Clinical assessment and family history collection.

Main Results:

  • The A3243G heteroplasmic point mutation in mitochondrial DNA was identified in the patient.
  • Despite 65% mutated mtDNA in muscle, standard morphological and biochemical tests did not reveal respiratory chain dysfunction.
  • Variable transmission of the A3243G mutation was observed in seven subjects across four generations.

Conclusions:

  • The A3243G mutation can present with headache as a primary symptom, even without overt signs of mitochondrial respiratory chain dysfunction.
  • Variable heteroplasmy levels and transmission patterns complicate genetic diagnosis and counseling for mitochondrial DNA mutations.
  • Further research is needed to understand the full clinical spectrum and inheritance complexities of mitochondrial DNA disorders.